Alibaba, payment firm to pay $600 million to settle US illegal drug sales probe

business crime & law big tech legal proceedings

Alibaba Group Holding Ltd and its US digital payment processor, AUS Merchant Services, have agreed to pay 600 million dollars to resolve a federal investigation. The U.S. Justice Department announced the agreement on Wednesday.

The investigation centered on whether the companies failed to prevent the sale and importation of illegal pharmaceuticals, controlled substances, and other restricted items into the United States. The payment resolves allegations that the firms allowed merchants to conduct these illegal sales.

The e-commerce giant admitted it failed to prevent 80,000 illegal drug product sales. As part of the resolution, Alibaba entered into a non-prosecution agreement to end the probe into the alleged violations.

Alibaba to pay $600m to settle illegal drug sales allegations in US probe

aljazeera.com

Alibaba, U.S. Payment Processor to Pay $600 Million in DOJ Settlement Over Illegal Drug Sales

wsj.com

Alibaba will pay 600 million dollars to settle a US probe into illegal pharmaceutical sales on its platform

thenextweb.com

Alibaba, Payment Firm Will Pay $600 Million to Resolve US Probe

bloomberg.com

Alibaba, AUS Merchant Services to pay $600 million to resolve alleged illegal pharmaceuticals sales, DOJ says

reuters.com